BioWorld Science

June 3, 2021

View Archived Issues

Novel synthetic biotic to promote mucosal healing for treatment of IBD

Read More

CIDEC gene silencing ameliorates experimental diabetic cardiomyopathy

Read More

Researchers develop new model of extracorporeal membrane oxygenation thrombosis

Read More

ADO-09 shown to be superior to insulin aspart in type 1 diabetes patients

Read More

ATTR removal observed in vitro and in vivo with NI-006

Read More

Encouraging development updates for SupraAntigen-derived liposomal AD vaccine candidates

Read More

Centivax enters strategic partnership with NMRC for phase I development of Centi-B9

Read More

First patient enrolled in phase Ib study of LB-100 for treatment of small cell lung cancer

Read More

Wave Life Sciences presents promising preclinical data for its ADAR editing program

Read More

Lophora ApS patents 5-HT2A receptor agonists

Read More

Nurix Therapeutics presents new PROTACs

Read More

Crinetics Pharmaceuticals synthesizes new melanocortin MC2 receptor antagonists

Read More

Merck & Co. identifies nicotinic alpha7 receptor PAMs

Read More

Suzhou Zelgen Biosciences synthesizes new GTPase KRAS mutant inhibitors

Read More

Phase II results presented from study comparing AZD-9567 versus prednisolone in active RA

Read More

Preclinical and early clinical characterization of VIB-7734

Read More

Epeleuton shows efficacy in preclinical models of atherosclerosis

Read More

New biomarkers identified for diagnosis of Cushing's syndrome

Read More

U.K. study identifies another danger of COVID-19: increased antibiotic resistance

Read More

Replimune provides updated clinical data for RP-1 and RP-2 programs

Read More

Mindset selects its lead next-generation psychedelic candidate, MSP-1014

Read More